Company intelligence / Profile preview

MY LINK

San Carlos, California, United Statesmylink.la ↗

Ownership: Private
Development stage: Other

Overview

Link Cell Therapies is a private biotech company developing next-generation cell therapies—primarily CAR T—for multiple cancer types. The team has deep experience in antibody discovery/development and nanoparticle drug delivery. Some programs are advancing toward or are in early clinical stages. No published pivotal trial results or commercialized products were identified as of June 2025.

Therapeutic areas: OncologyInfectious Diseases
Modalities: CAR-T cell therapyMonoclonal antibodyNanoparticle (for targeted delivery)Antibody-drug conjugate (historical expertise of key personnel)
Industry: Biotech

Beyond the preview

Go deeper on MY LINK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MY LINK.

Explore the full profile